Roivant Sciences ROIV
NASDAQ ROIV
$41.85 +0.66 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Roivant Sciences (ROIV) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Roivant Sciences (ROIV) reported Return on Capital Employed [ROCE] of -11.41% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 11.75 percentage points from -23.16% a year earlier but down 1.48 percentage points from the prior quarter.

Analysis

Roivant Sciences (ROIV) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Roivant Sciences posted Return on Capital Employed [ROCE] of -9.73%, up 6.50 percentage points from FY2025.

  • Return on Capital Employed [ROCE] has a four-year change of +46.51 percentage points (FY2022 to FY2026).
  • By fiscal year, Return on Capital Employed [ROCE] came in at -16.23% in FY2025 (-115.30 pp), 99.07% in FY2024 (+140.01 pp), -40.94% in FY2023 (+15.31 pp) and -56.25% in FY2022.
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -66.20% in fiscal Q2 2022 and a high of 105.12% in fiscal Q3 2024.
  • Year over year, Return on Capital Employed [ROCE] gained in three of the last eight quarters, with an average year-over-year change of -32.67 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was fiscal Q3 2024 (a gain of 166.59 percentage points); the low point was fiscal Q3 2025 (a drop of 120.91 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -9.93% (Q4 2026), -24.34% (Q3 2026) and -23.41% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Roivant Sciences 29.81 Bn 13.51 Bn 31.77 Mn -11.48%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -11.48%
Jun 30, 2026 -11.41%
Mar 31, 2026 -9.93%
Dec 31, 2025 -24.34%
Sep 30, 2025 -23.41%
Jun 30, 2025 -23.16%
Mar 31, 2025 -18.36%
Dec 31, 2024 -15.79%
Sep 30, 2024 77.25%
Jun 30, 2024 69.30%
Mar 31, 2024 63.28%
Dec 31, 2023 105.12%
Sep 30, 2023 -45.44%
Jun 30, 2023 -44.64%
Mar 31, 2023 -44.80%
Dec 31, 2022 -61.47%
Sep 30, 2022 -49.42%
Jun 30, 2022 -65.36%
Mar 31, 2022 -53.90%
Dec 31, 2021 -58.26%
API Access

Roivant Sciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEY